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Abstract
Human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) are ubiquitous respiratory pathogens of the
Pneumovirinae subfamily of the Paramyxoviridae. Two major surface antigens are expressed by both viruses; the highly
conserved fusion (F) protein, and the extremely diverse attachment (G) glycoprotein. Both viruses comprise two genetic
groups, A and B. Circulation frequencies of the two genetic groups fluctuate for both viruses, giving rise to frequently
observed switching of the predominantly circulating group. Nucleotide sequence data for the F and G gene regions of HRSV
and HMPV variants from the UK, the Netherlands, Bangkok and data available from Genbank were used to identify clades of
both viruses. Several contemporary circulating clades of HRSV and HMPV were identified by phylogenetic reconstructions.
The molecular epidemiology and evolutionary dynamics of clades were modelled in parallel. Times of origin were
determined and positively selected sites were identified. Sustained circulation of contemporary clades of both viruses for
decades and their global dissemination demonstrated that switching of the predominant genetic group did not arise
through the emergence of novel lineages each respiratory season, but through the fluctuating circulation frequencies of
pre-existing lineages which undergo proliferative and eclipse phases. An abundance of sites were identified as positively
selected within the G protein but not the F protein of both viruses. For HRSV, these were discordant with previously
identified residues under selection, suggesting the virus can evade immune responses by generating diversity at multiple
sites within linear epitopes. For both viruses, different sites were identified as positively selected between genetic groups.
Citation: Gaunt ER, Jansen RR, Poovorawan Y, Templeton KE, Toms GL, et al. (2011) Molecular Epidemiology and Evolution of Human Respiratory Syncytial Virus
and Human Metapneumovirus. PLoS ONE 6(3): e17427. doi:10.1371/journal.pone.0017427
Editor: Ron Fouchier, Erasmus Medical Center, Netherlands
Received November 5, 2010; Accepted February 2, 2011; Published March 1, 2011
Copyright:  2011 Gaunt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by a studentship awarded to E.G. by the BBSRC, the Thailand Research Fund, the Commission on Higher Education, King
Chulalongkorn Memorial Hospital, the Center of Excellence in Clinical Virology and CU Centenary Academic Development Project, Chulalongkorn University. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: e.gaunt@sms.ed.ac.uk
Introduction
Human respiratory syncytial virus (HRSV) and human
metapneumovirus (HMPV) are globally ubiquitous respiratory
pathogens of the Pneumovirinae subfamily of the Paramyxoviridae.
Both viruses comprise two genetic groups, A and B, distinguishable
genetically and serologically [1–3] which co-circulate with
fluctuating frequencies. The two HRSV genetic groups are
referred to as subgroups; these comprise genotypes distinguished
on the basis of antibody cross reactivity [4] or phylogeny [5]. Each
of the two HMPV genetic groups are referred to somewhat
paradoxically as genotypes, and each genotype comprises two sub-
genotypes (A1, A2, B1 and B2). HMPV genotypes are distin-
guishable serologically and sub-genotypes are discerned phyloge-
netically [3].
Fluctuating circulation frequencies of HRSV subtypes and
HMPV genotypes give rise to the observation of switching of the
predominantly circulating subtype (HRSV) or genotype (HMPV)
between respiratory seasons [6–13]. HMPV was discovered in
2001 and so longitudinal epidemiologic studies are infrequent,
though for HRSV a theme of cyclicity whereby subtype A
predominates for a number of seasons then subtype B predom-
inates (usually for a shorter duration) are reported [14–19].
HRSV-A is considered the major subtype in terms of both
frequency [20] and associated morbidity [7]. Similarly, HMPV-A
strains are generally detected at a higher frequency than HMPV-B
strains [12,13,21] and clinical differences are reported between
HMPV genotypes [21,22]. Repeat HRSV infections occur
throughout life with decreasing morbidity, and increasingly
evidence suggests the same is also true for HMPV [3,23–27].
The HRSV and HMPV virions both express two highly
immunogenic surface proteins against which adaptive immune
responses are directed. The fusion (F) protein mediates fusion of
viral and cell membranes and is highly conserved. Anti-HRSV
antibody directed against F protein is cross-reactive for strains of
both subtypes [1,2,28,29], and studies on HMPV using human
sera and animal models have indicated similar antibody reactivity
patterns [30–33]. It is conceivable that the conformational changes
arising on activation of the fusion protein [34] serve to expose the
conserved functional (and immunogenic) regions (analogous to the
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native state, sheltered from immunologic recognition.
The attachment (G) glycoprotein of pneumoviruses conversely
portrays several immune evasive traits. Specificity of antibody
raised against the G protein extends to, and possibly beyond, the
genotype level (HRSV) or sub-genotype level (HMPV)
[4,29,30,36–38]. In both viruses the G protein is extensively
glycosylated with both N- and O-linked sugars and a high
proportion of proline residues [39,40] thought to reduce ordered
secondary structure of the protein [41].
The highly variable G protein of HRSV comprises 298 [42] or
318 [43] residues. Two mucin-like hypervariable regions (HVRs)
at the C terminus under significant positive selection form
hydrophilic stalk like protrusions from the surface of the virion
separated by an exposed [44] but conserved and non-glycosylated
region comprising residues 151–190 [45]. A heparin binding
domain (HBD) identified between residues 184–198 (subgroup A)
or 183–197 (subgroup B) binds heparin-like glycosaminoglycans
(GAG) on the host cell surface [46]. A fourteen residue region
incorporating four universally encoded cysteine residues at
positions 173, 176, 182 and 186 believed to form disulphide
bridges is common to human and bovine RSVs [47], and the G
protein has been shown to bind host cell receptor CX3CR1 via the
CX3C chemokine domain accommodating cysteine residues at
positions 182 and 186 [48]. Interestingly, subtype specific
seroconversion directed against this antigenic region is detectable
in only 40% of individuals [49].
The HMPV G protein, which comprises 217 to 236 residues
[50,51] has not been resolved in such detail. Nevertheless, great
variability in the C terminal ectodomain is seen; conversely to
HRSV, no conserved cysteine pairs or chemokine domains are
detectable. HMPV does not encode a conserved methionine or
alternative initiation codon in or adjacent to the transmembrane
region which would permit production of a secreted form of the G
protein, unlike HRSV [52].
It is hypothesized that switching of the predominant circulating
subtype of HRSV is brought about by short-lived subtype-specific
herd immunity in a population generated over one or two seasons,
which favours dissemination of the alternate subtype in a
subsequent season [43,53,54]. This suggestion has been borrowed
to explain HMPV genotype switching also [12].
Evolutionary modelling of several respiratory viruses has been
undertaken. A well conducted analysis which identified positively
selected sites and the evolutionary characteristics of HRSV was
bipartite, corresponding with the two subtypes A and B [10,11].
Sequence data spanning 47 and 45 years (for subtypes A and B
respectively) were used to identify positively selected sites within the
attachment (G) protein, to distinguish residues which had a
significant likelihood of being O-glycosylated (a mechanism used
to shelter residues from immunologic recognition [55]), and to
determine the time since the most recent common ancestor (tMRCA)
of the HRSV species – which was estimated to have existed 350
years ago.
The evolutionary dynamics of the closely related HMPV have
alsobeenexplored [56–58]. ThetMRCAofthe HMPV sub-genotypes
wereestimated at 12–28 years,and the two genotypes were found to
have mean tMRCAs of 26–51 years [56–58]. The tMRCA across the
species in one study was 119–133 years [56], whereas another study
using sequence data collected over a greater number of years
determined a more recent species level tMRCA of 97 years [58],
though both analyses were conducted using similar sequence data
and the same software package (BEAST [59]).
Many human infecting viruses, both in the field of respiratory
medicine and more widely, undergo a turnover and replacement
of predominant lineages with emergent strains. For example,
clades of echoviruses 9, 11 and 30 are frequently replaced by novel
recombinant forms with striking periodicity [60], dengue virus
serotypes are comprised of clades undergoing replacement [61],
and measles virus clade replacement is described, the latter of
which is likely due to selective advantages brought about by the
vaccine era [62]. HRSV and HMPV have not previously been
discussed in such terms, and so it was decided to investigate
whether similar evolutionary mechanisms are evident for HRSV
and HMPV.
We report identification and evolutionary modelling of three
geographically dispersed contemporary clades of HRSV and five
of HMPV, which have circulated for decades. Switching of the
predominantly circulating genotype (HMPV)/subtype (HRSV)
therefore cannot be attributed to the emergence of novel virus
lineages. Identification of numerous sites under positive selection
in the G proteins of both viruses were frequently discordant with
those identified in previous studies, and little overlap in positively
selected sites was observed between HRSV subtypes or HMPV
genotypes. The interpretations of these findings are discussed.
Results
Circulating clades of HRSV and phylogenetic
reconstructions
To investigate the geographical and temporal distribution of
individual clades of each virus, phylogenetic analyses were
performed on 243 HRSV and 310 HMPV F gene sequences
with isolation dates spanning 44 and 26 years respectively (Fig. 1).
Three clades of HRSV with sufficient sequences available were
identified (labelled 1–3; Fig. 1A), of which two were subtype A,
and one was subtype B.
HRSV subtype B sequences largely grouped into the one clade,
and all but three subtype B sequences falling outside this clade
were collected before 2002. HRSV subtype A sequences mostly
fell into one of two clades, with all but one of the sequences not
belonging to one of the identified clades having a collection date
prior to 2002. There was little evidence of geographical clustering
of HRSV sequences, with strains from Newcastle, the Netherlands
and Bangkok phylogenetically interspersed among the Edinburgh
strains in all three clades (Fig. 1A). HRSV clade 1 was comprised
entirely of sequences generated during this study, whereas clades 2
and 3 incorporated sequences downloaded from Genbank of Asian
origin.
Phylogenetic analyses comparing the same 58 HRSV isolates
sequenced in the F and G gene regions (Fig. 2) reveals congruence
between the two datasets with sequence clusters supported by a
70% bootstrap threshold consistent over the two genome regions.
(Greater bootstrap support was evident in the G gene, reflective of
the greater diversity seen in this region.) Closer inspection of the
HRSV-A F and G gene phylogenies revealed two monophyletic
lineages (Fig. 2). Directional evolution of the two HRSV-A
lineages is evident visually.
Identification of positively selected sites in the HRSV
genes encoding surface proteins
To further understand the evolutionary pressures acting on
HRSV and HMPV, analyses to detect codons under positive
selection in the F and G genes of both viruses were undertaken. No
positively selected codons were identified in the F gene of HRSV
clades, findings that contrasted markedly with the 32 positively
selected sites detected within the HRSV-A G gene and 5 in the
HRSV-B G gene (Table 3). The codon encoding residue 258 was
the only residue identified as positively selected for both subtypes.
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HMPV phylogenetic reconstructions revealed 5 main mono-
phyletic groups corresponding with five major clades, one within
sub-genotype B1, and two each within sub-genotypes A2 and B2
(labelled 1–5; Fig. 1B). The availability of geographically diverse
HMPV-F sequences in Genbank allowed identification of strains
from at least two, and up to four continents within clades 2, 3, 4
and 5. Clade 1 was the exception, comprised entirely of strains
from Edinburgh and the Netherlands. Older HMPV strains
clustered to the internal nodes of the tree. HMPV G protein
sequence data available in Genbank spanning 11 years between
1997 and 2008 was analysed phylogenetically (Fig. 3). This also
revealed geographically disparate strains interspersed phylogenet-
ically, and that several identified lineages circulated concurrently,
confirming the observations drawn from the F gene phylogenetic
analysis, and comparable with HRSV. Together with the strong
evidence of directional evolution, this is indicative of epidemiologic
and evolutionary traits shared by the two members of the
Pneumovirinae.
HMPV strains from Bangkok were exclusively of genotype A,
though previously determined strains of Japanese origin grouped
in genotype B (clades 2 and 3). One unusual HMPV genotype A
sequence from the Netherlands (NL20850160/08.042) did not
group into either sub-genotype A1 or A2. Despite sampling from
three globally distributed referral centres collected over two years,
we were unable to identify any sequences belonging to the HMPV
A1 sub-genotype.
Positive selection in the HMPV surface proteins
Analysis of the F gene of HMPV-B sub-genotypes yielded only
two positively selected codons in the B2 group at residues 391
(p=0.870)) and 400 (p=0.664). Within the G gene of HMPV-A,
fourteen codons were positively selected, six were positively
selected within HMPV-B1 and 17 sites were identified as under
positive selection within HMPV-B2 (Table 3). For HMPV-A,
HMPV-B1 and HMPV–B2, sites identified as under positive
selection were usually different between groups, except residue 110
which was identified in all three groups.
HRSV-F and HMPV-F clade turnover
Evolutionary analyses of three HRSV-F and five HMPV-F
clades was undertaken to determine the minimum length of time
monophyletic lineages of both viruses have been circulating
(Table 4). Strict molecular clock models were always used under
the assumption that the evolutionary rate within a clade did not
vary. Analysis of the HRSV-B clade (clade 1, Fig. 1A) was
unable to yield an ESS.200, likely due to the low diversity
encompassing most F gene sequences within the subtype and so
was excluded from analyses. Indeed, in this clade, visual
evidence of directional evolution was not evident from
phylogenetic analysis. The tMRCA of HRSV-A clades was 17
and 14 years and of HMPV clades was between 11 and 27
years. Genetic diversity across HRSV and HMPV clades was
around 2–3% (Table 4). Congruent tMRCA,d i v e r s i t ya n d
substitution rates of clades of both viruses (Table 4) support
the existence of evolutionary mechanisms common to both virus
species.
Discussion
HRSV and HMPV sequence data generated from isolates
collected over 44 years and 26 years respectively were analysed
using a variety of techniques, including phylogenetic reconstruc-
tion, evolutionary modelling and identification of positively
selected sites to gain insight into the epidemiology and evolution
of these closely related viruses. Identification of contemporary
HRSV and HMPV clades was undertaken for evolutionary
modelling, to further understanding of the circulation trends of
predominant virus lineages. Evolutionary analyses of the
Pneumovirinae have not previously been approached in this way.
The evolutionary rates of F gene sequences for HMPV clades in
the range of 1.0–1.7610
23 substitutions/site/year (Table 4) are
slightly higher, albeit within the 95% highest posterior density
(HPD) intervals, than the rates calculated in previous studies
sampling across the species of 0.9610
23 [56] and 0.712610
23
substitutions/site/year [57]. It has previously been noted that
external branches of the HMPV-F phylogenetic reconstruction
have higher dN/dS ratios than internal branches [56]. Taken
together, these observations suggest that substitutions are more
frequently selected for in the contemporary virus population than
previously. This might be explained by an increasing virus
population size – random sampling of a larger virus population
increases the likelihood of detection of nucleotide changes, and
increasing population size increases the probability that residue
changes will be selected for.
Previous calculation of the evolutionary rate of HRSV has
been undertaken by analysing G gene sequence data, with rates
of 1.83610
23 and 1.95610
23 substitutions/site/year determined
for subtypes A and B respectively [10,11]. These rates are slightly
higher than those calculated here for the F protein (1.3–
1.5610
23 substitutions/site/year). A higher evolutionary rate in
the G protein than the F protein has similarly been observed for
HMPV [56]. The G protein is under evolutionary pressure due to
the host population adaptive immune response to this immuno-
genic region [45,63–66]. Nucleotide substitutions, most com-
monly those which are non-synonymous, are frequently selected
for, and as nucleotide changes become fixed in the population
they are more likely to be captured by the evolutionary analyses,
which might explain why the model yields higher rates in this
region. Conversely, the extremely low dN/dS ratio and lack of
positively selected sites in the F protein [67] provides evidence
that changes in the F protein are deleterious, probably due to
functional constraints.
For both HMPV and HRSV, we have identified an abundance
of sites under positive selection within the G gene, but few within
the F gene. In HRSV-A, we identified 32 sites under positive
selection. Previous analysis to detect positively selected sites
within HRSV-A [10] identified twelve positively selected sites
using sequence data spanning a similar time frame, with 48
sequences analysed compared with 139 here; 9 residues were
identified by both analyses (111, 117, 215, 226, 262, 274, 276,
290, 297). The previous study used the same program and
threshold for significance, and similar models and sampling frame
in terms of the number of representative strains and date range
analysed. An explanation of this incongruence might be in the
differences between the predominantly circulating lineages of the
Figure 1. Phylogenetic analysis of HRSV (A) and HMPV (B) partial F gene sequences. Phyogenetic reconstruction was by neighbour joining
of MCL-corrected pair-wise distances. Clades identified as described in the methods are indicated by grey shaded boxes. Sequence symbols are
colour coded by year of isolation. Symbol shape denotes geographic origins sequences. Bootstrap values .70% are indicated. (A) Phylogenies rooted
with bovine RSV (not shown). Subgroups A and B are indicated by the blue and yellow boxes respectively. (B) rooted with avian metapneumovirus
species C (not shown). Genotypes A and B are indicated by the blue and yellow boxes respectively. NA, None analysed.
doi:10.1371/journal.pone.0017427.g001
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under dissimilar structural or immunologic constraints. Alterna-
tively, we may have identified more positively selected sites due to
the larger dataset analysed. The HRSV residues identified as
under positive selection 142, 206, 274 and 286 have been
associated with substitutions in successful antibody escape
mutants [68–70]. The positively selected residues 215, 217 and
226 fall within a region thought to be immunogenic of
neutralising antibodies [71,72], and residue 297 has previously
been identified as a determinant of the integrity of multiple
overlapping strain-specific epitopes [73].
An inability of antibodies to select for mutations at sites
autonomous to their binding specificity has previously been used
to support the notion that HRSV-G epitopes are linear rather
than conformational [45]. The greatest distance between any two
residues identified as under positive selection within HRSV-A,
excluding the conserved region between residues 151–190 (in
which we identified one residue under positive selection at
position 161), was eight amino acids, which suggests that HRSV-
A might potentially generate variability in any epitope of the G
protein. The four residues identified as under positive selection in
the previous study which were not verified through this work
were nevertheless proximal to residues identified as positively
selected in this study, with the greatest distance between the two
being four amino acids. This supports the notion that within
epitopes, changes in any residue might be selected for immune
evasion.
For HRSV-B, only five residues were identified as under
positive selection, compared with twelve during a previous study.
Again, we analysed a greater number of sequences than previous
work, though both studies used sequences generated from samples
collected over a similar time frame [11]. Here, all the identified
sites under positive selection were in the second hyper-variable
region in the ectodomain, and only two of the five residues we
identified as positively selected were also identified as positively
selected previously. Two of the discordant sites we identified were
within or downstream of the previously identified [11,43] 60
nucleotide repeat insertion at the 39-proximal end of the G protein
gene, and so it is possible that these sites were not detected by
previous analyses due to limited availability of sequence data for
the insert region. Residue 224, the third amino acid not previously
identified as such, was determined as positively selected with a
probability of p=0.501, and was not detected by the Naı ¨ve
Empirical Bayes test (used in previous analyses), accounting for the
discordancy at this residue between studies.
Six-nucleotide in frame deletions at amino acid positions 159
and 160 reported previously [11] were observed in four of the
Newcastle HRSV isolates from 1985, 1986 and 2009. This
occurred in different bootstrap-supported lineages of the G
region phylogenetic tree, providing strong evidence that this
deletion has been independently selected for more than once.
Recent identification of two epitopes within the central
conserved region of the HRSV G protein ectodomain between
residues 151–163 and 164–176 [49] illustrates the immunoge-
nicity of these two peptide regions, while an investigation of the
properties of the central conserved domain of HRSV-G showed
that the region between amino acids 149–177 played no role in
virus infectivity [74]. A loss of these two residues may therefore
reduce virus immunogenicity while having no effect on virus
infectivity. These observations, together with previous reports of
premature stop codons and frame shifts within the subgroup B
G protein [71,73,75], suggest that HRSV-B may use quite
different mechanisms from HRSV-A to evade host immune
responses.
A number of residues were identified as positively selected
within the G protein of HMPV types A, B1 and B2 (14, 6 and 17)
which were differentially located between lineages, in keeping with
the observations made of HRSV. There is a predicted cytotoxic T
cell epitope between residues 32–41 [76], and within this region
one site was identified as positively selected within HMPV-A. The
residue identified as under positive selection in all three HMPV-G
analyses (residue 105) is not a predicted site of N- or O-
glycosylation [51].
Phylogenetic analyses of HRSV and HMPV yielded the
common observation that strains isolated from geographically
widespread referral centres frequently resolved within the same
lineage, reflecting the ability of these viruses to disseminate rapidly
on a global scale, and substantiating previous reports of the
worldwide distribution of lineages of both viruses [11,63,68,77].
Switching of the predominantly circulating genotype (HMPV)/
subtype (HRSV) in a population is widely discussed, but poorly
understood in terms of what drives these events or the
mechanisms by which they occur. The MRCA estimates for
contemporary circulating clades were for HRSV and HMPV 14–
17 and 11–28 years respectively, providing conclusive evidence
that switching of the predominantly circulating genetic group of
both viruses arises independently of novel lineage emergence
events. The differences in evolutionary rates between older and
more recent HMPV isolates, interpreted here as evidence of an
increasing population size, contradicts a previous analysis which
showed that one HMPV lineage was increasing in size whereas
another was decreasing [57]. Taken together, this information
lends to the hypothesis that HMPV (and HRSV) lineages
circulate in a cyclic trend of multiple eclipse phases preceding
periodic population expansions. Proliferation occurs when the
lineage is of minimal susceptibility to the adaptive immune
responses of the host population, and a regression in circulating
frequency occurs as the host population is increasingly exposed.
During the eclipse phase, the virus evolves immune evasive
characteristics, which when accumulated sufficiently permit a
new phase of widespread circulation.
In summary, we have analysed the molecular epidemiology and
evolution of HRSV and HMPV in parallel using the novel
approach of clade identification for evolutionary analysis. This
work has revealed a number of shared trends, including evidence
of both locally and globally circulating lineages of both viruses,
significant positive selection acting in the G but not the F genes
and a lack of evidence for positive selection being restricted to
specific codons. Switching of the predominantly circulating
subtype (HRSV) or genotype (HMPV) may be a result of
fluctuating circulating frequencies of contemporary clades, which
cycle through proliferative and eclipse phases, and is not due to
novel lineage emergence events. We suggest that HRSV has the
ability to select for residue substitutions at multiple sites within
Figure 2. Phylogenetic analysis of 58 HRSV sequences in the F and G genes. Phylogenetic reconstruction was by neighbour joining of MCL-
corrected pair-wise distances. F gene sequences rooted with bovine RSV; G gene sequences unrooted. Sequence symbols are colour coded by
geography to emphasize the congruence between the phylogenies of the two genome regions. Monophyletic groupings which contain sequences
from the 07/08 respiratory season for which sequence data was available from all four referral centres are indicated in shaded boxes. Bootstrap values
.70% are indicated.
doi:10.1371/journal.pone.0017427.g002
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incidence of lineages of this virus.
Methods
Sample collection
HRSV and HMPV positive respiratory samples archived
between March 2006 and December 2008 at the Specialist
Virology Centre (SVC), Royal Infirmary of Edinburgh, UK were
identified as described previously [13]. 26 HRSV isolates were
collected between 1965 and 2009 from Newcastle, UK [6].
Additionally, nine HRSV and eight HMPV positive samples from
Bangkok, Thailand (2006–07 respiratory season) detected as
described previously were included in analyses [78] along with
16 HRSV and 16 HMPV variants from the Academic Medical
Centre, Amsterdam, Netherlands from the 2007–8 season.
Figure 3. Phylogenetic analysis of HMPV partial G gene sequences (unrooted). Phylogenetic reconstruction was by neighbour joining of
MCL-corrected pair-wise distances. Genotypes (A and B) and sub-genotypes (A1, A2, B1 and B2) are indicated. Sequence symbols are colour coded by
year of isolation and symbol shape is designated depending on geographic origin of sequence. Bootstrap values .70% are indicated.
doi:10.1371/journal.pone.0017427.g003
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sequencing in the F and G genes
All HRSV (n=183) and HMPV (n=177) positive respiratory
samples were amplified nd sequenced in the 39 F gene region as
previously described [13] (589 and 438 nucleotides respectively).
For HRSV, all 26 isolates from Newcastle, seven from Bangkok,
16 from the Netherlands and eight from the UK were amplified in
the 39 G gene region that included both HVRs (780 nucleotides).
Combined, the HRSV variants analysed were globally distributed
and spanned 44 years. These were analysed alongside available
HMPV G gene sequences in Genbank, which encompassed a
temporal diversity of 12 years.
HRSV and HMPV RNA was extracted using Qiagen QIAamp
viral RNA mini kit and reverse transcribed using Qiagen A3500
reverse transcription system, with extended elongation of 55 min-
utes and use of random primers. HRSV and HMPV cDNAs were
amplified by nested PCR. Reaction mixtures contained 4 ml
MgCl2, (25 mM), 0.2 ml dNTP (3 mM), 1 ml each outer primer
(10 mM) and 0.08 ml TaqPolymerase. Primers for HRSV-F gene
PCR were (outer sense) 916- TAT GGW GTD ATA GAY ACM
CCY TGY TGG, (inner sense) 1018- GG RTG GTA YTG TGA
YAA TGC AGG, (inner antisense) 1663-CT TAR TGT RAC
TGG TGT GYT TYT GGC and (outer antisense) 1682- TWC
CAC TYA GTT GRT CYT TRC TTA RTG. HRSV-G gene
was amplified by primers (outer sense) 47- CCT GGG AYA CTC
TYA ATC AT, (inner sense) 137-TGG CAA TGA TAA TCT
CAA C (inner antisense) 117- CCT YTG CTA ACT GCA CT
and (outer antisense) 147-GTA TAC CAA CCW GTT CTT A;
antisense primers align in the downstream fusion gene. Primers for
HMPV F gene amplification were as described previously [13].
2 ml cDNA was used in the first round and 1 ml first round product
was used in the second round reaction. The same cycling
conditions were used throughout; 30 cycles at 94uC for 18 s,
50uC for 90 s and 72uC for 30 s, and a terminal 72uC elongation
step for 300 s.
Sequences obtained in the course of this study have been
submitted to GenBank and assigned accession numbers
GU386461–GU386756 (HMPV and HRSV F gene) and
HQ731687–HQ731784 (HRSV G gene).
Phylogenetic analysis
A summary of the computational techniques undertaken for this
work and the sequence datasets analysed is tabulated (Table 1).
Partial F gene sequences were aligned and genetic distances were
calculated using Simmonics v1.9 sequence editor package (www.
virus-evolution.org). Phylogenetic trees were constructed from
1000 samplings of maximum composite likelihood (MCL)
distances by neighbour-joining method with pair-wise deletions
for missing nucleotides in MEGA v4.0. For HRSV, 58 isolates
were available for sequencing in both F and G gene regions, and
these subsets were phylogenetically analysed separately for
comparison using the same methods. HMPV-G sequences
downloaded from Genbank were analysed altogether (unrooted).
The dataset parameters used for phylogenetic reconstructions are
summarized (Table 2).
Identification of HRSV-F and HMPV-F clades
No systematic method is currently used for identification of
distinct HRSV and HMPV lineages. HRSV and HMPV clades
(defined as described herein) were identified for the purpose of
evolutionary modelling. Phylogenetic analyses of F gene nucleotide
sequences of contemporary HRSV and HMPV strains (generated
from samples collected since 2007) were constructed as described
above for identification of bootstrap-supported monophyletic
lineages (values $70%) using MEGA v4.0. Subsequent phyloge-
netic analyses incorporated older monophyletic sequences within
the contemporary clades, with visually appropriate limitations of
1.5–3% variation across clades at the nucleotide level and no
individual sequence varying from all others within the clade by
more than 0.5% at the nucleotide level.
Table 1. Summary of the evolutionary analyses undertaken by taxomonic group.
Taxonomic group Gene Analyses undertaken (software used)
Nucleotide sequencing
(Simmonics)
Phylogenetic
(MEGA)
Positive selection
(PAML) Evolutionary (BEAST)
HRSV spp F 66
HRSV spp G 66
HRSV-A F 66
HRSV-B F 66
HRSV-A G 66
HRSV-B G 66
HRSV clades F 6 6
HMPV spp F 66
HMPV spp G 6
HMPV-A2 F 66
HMPV-B1 F 66
HMPV-B2 F 66
HMPV-A G 6
HMPV-B1 G 6
HMPV-B2 G 6
HMPV clades F 6 6
doi:10.1371/journal.pone.0017427.t001
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of HMPV and HRSV clades and the G protein of
genotypes/subtypes
Prior to evolutionary analyses, positively selected sites were
removed from nucleotide alignments. This was considered
necessary as positively selected sites undergo convergent evolu-
tion whereas other sites are subject to neutral or nearly neutral
drift, and different evolutionary mechanisms inevitably violate
assumptions of the SRD06 evolutionary model [59]. Nucleotide
alignments of HRSV and HMPV subtypes/sub-genotypes were
analysed for positive selection using PAML v4.4. In the
attachment protein of HRSV, species level analyses detected all
sites in the ectodomain as positively selected due to the high
diversity in this region, and similar results were produced for the
HMPV species level analyses. This was likely also affected by the
large amount of sequence data available. To conserve the
maximum diversity in the sequence dataset analysed, analyses for
positive selection were undertaken in decreasing increments of
taxonomic diversity until satisfactory results were attained. This
was found to be the subtype level for HRSV and the sub-
genotype level for HMPV. The recommended combination of
models 0, 1a and 2a [79] were run and Bayes empirical Bayes
results only were considered as recommended. The genome
regions analysed for the different virus subgroups are summarized
(Table 2). Nucleotide alignments with positively selected sites
removed were reanalysed in PAML to confirm no positive
selection was detected.
Clade turnover
Identical sequences (bygeography,date and nucleotide sequence)
within clades were removed, and evolutionary analyses were
restricted to clades with a minimum of 15 non-identical sequences.
Three HRSV and five HMPV clades were identified (indicated on
Fig. 1). Evolutionary analyses of HRSV and HMPV clades were
undertaken using BEAST to calculate evolutionary rates and time
since the most recent common ancestor (tMRCA) of genetic groups.
The F gene region was selected as it was more phylogenetically
informative, not subject to positive selection and sequences from a
wider geographical and temporal range were available. Clade
sequence datasets were run in BEAST using a strict SRD06 model,
which allows the third position in a codon to have a different
substitution rate to the first and second, until all ESS (expected
sample size) values exceeded 200 (recommended). The strict model,
as opposed to a relaxed model, assumes that all lineages
incorporated within the sequence dataset evolve at the same rate.
As the sequence datasets described here were by definition
monophyletic groups, the assumption of a nonvariable evolutionary
rate within each group was justified. Analyses were run in duplicate
to ensure convergence of the posterior distribution, demonstrating
repeatability of the result. The coefficient of variationhistogramwas
used to confirm validity of the strict model.
Table 2. Sequence datasets for phylogenetic and for positive selection analyses.
Virus group Gene Region analysed Reference strain
Root for phylogenetic
reconstruction
HRSV-A G Residue 13 to C terminus Long HRSV-B
HRSV-B G Residue 35 to C terminus WV/B1/85 HRSV-A
HRSV F Residues 358–554 Long Bovine RSV
HMPV-A1 G Residue 1 to C terminus Analysed for positive selection only
HMPV-B G Residue 35 to C terminus Analysed for positive selection only
HMPV G Residue 35 to C terminus CAN97-83 Unrooted
HMPV F Residues 385–531 CAN97-83 AMPV-C
doi:10.1371/journal.pone.0017427.t002
Table 3. Positively selected sites detected in the attachment (G) protein of HRSV and HMPV.
Group
Reference
strain Positively selected sites
Frequency of positively selected sites identified in probability
range
0.5–0.6 0.6–0.7 0.7–0.8 0.8–0.9 0.9–1.0
HRSV-A Long 101, 104, 106, 111, 115, 117, 121, 122,
123, 126, 127, 131, 142, 146, 161, 206,
215, 217, 226, 230, 233, 250, 258, 262,
274, 276, 280, 286, 289, 290, 291, 297
1 3 4555
HRSV-B WV/B1/85 223, 224, 258, 267/287
1, 297/317 1 2 1 1
HMPV-A CAN97-83 33, 81, 84, 93, 105, 106, 110, 145, 146,
157, 165, 172, 177, 190
32351
HMPV-B1 CAN97-83 70, 100, 105, 116, 162, 201 2 3 1
HMPV-B2 CAN97-83 53, 55, 85, 89, 93, 105, 109, 111, 121,
126, 137, 141, 180, 202, 207, 217, 222
48311
1Refers to strains without/with the 60 nt repeated region.
doi:10.1371/journal.pone.0017427.t003
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